Form 4 for HAE HAEMONETICS CORP
Accepted 2026-05-19 17:33:01 ET · period of report 2026-05-15 · accession 0000313143-26-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 17:33 | 2026-05-15 | HAE | Maunsell Farris Maryanne | VP, CAO | F - Tax | $56.29 | -197 | 4,281 | -4% | -$11.1K | |
| 2026-05-19 17:33 | 2026-05-15 | HAE | Maunsell Farris Maryanne | VP, CAO | A - Grant | — | +2,220 | 6,501 | +52% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | F | D | 197 | $56.29 | 4,281 | D | — | — | (F1) Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. (F2) This number includes unvested RSUs previously reported. |
| 2 | Common | Common Stock | 2026-05-15 | A | A | 2,220 | — | 6,501 | D | — | — | (F3) The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. (F4) Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. (F2) This number includes unvested RSUs previously reported. |